Colchicine in breast milk of patients with familial mediterranean fever
โ Scribed by Eldad Ben-Chetrit; Jean-Michel Scherrmann; Micha Levy
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- English
- Weight
- 357 KB
- Volume
- 39
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
In order to demonstrate the effect of prophylactic colchicine treatment on the natural history of familial Mediterranean fever (FMF), a family is presented with 6 out of 9 siblings affected by FMF. Each patient represents a different stage of the amyloidotic kidney disease of FMF a n d the effect of
BEFORE 2 4 6-12 months Figure 3. Level of C4 in SLE patients before and during levamisole treatment. observations correspond to several studies previously reported, which also contradict the findings to Hadidi et al.
Recurrent polyserositis (RP) is manifested by short, self-limited attacks of fever, peritonitis, pleurisy, and arthritis. Because this disease affects mainly Jews, Armenians, Arabs, and Turks, it has also been called familial Mediterranean fever. The first symptoms occur before the age of 20 years i